A1D8Y

5-[4-[[6-(4-methylsulfonylphenyl)pyridin-3-yl]oxymethyl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole



Chemical Component Summary

Name5-[4-[[6-(4-methylsulfonylphenyl)pyridin-3-yl]oxymethyl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole
SynonymsGSK1292263
Identifiers5-[4-[[6-(4-methylsulfonylphenyl)pyridin-3-yl]oxymethyl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole
FormulaC23 H28 N4 O4 S
Molecular Weight456.558
TypeNON-POLYMER
Isomeric SMILESCC(C)c1nc(on1)N2CCC(CC2)COc3ccc(nc3)c4ccc(cc4)S(=O)(=O)C
InChIInChI=1S/C23H28N4O4S/c1-16(2)22-25-23(31-26-22)27-12-10-17(11-13-27)15-30-19-6-9-21(24-14-19)18-4-7-20(8-5-18)32(3,28)29/h4-9,14,16-17H,10-13,15H2,1-3H3
InChIKeyAYJRTVVIBJSSKN-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count60
Chiral Atom Count0
Bond Count63
Aromatic Bond Count17

Drug Info: DrugBank

DrugBank IDDB12627 
NameGSK-1292263
Groups investigational
DescriptionGSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.
SynonymsGSK-1292263
CAS number1032823-75-8

Related Resource References

Resource NameReference
Pharos CHEMBL3187503
PubChem 24996872
ChEMBL CHEMBL3187503